Jane Street
STOK icon

Jane Street’s Stoke Therapeutics STOK Stock Holding History

Jane Street’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$339K Sell
10,400
-4,700
-31% -$154K ﹤0.01% 8964
2025
Q4 		$479K Buy
+15,100
New +$454K ﹤0.01% 7788
2024
Q2 		– Sell
-12,200
Closed -$165K – 10161
2024
Q1 		$165K Buy
+12,200
New +$73.9K ﹤0.01% 8288

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Jane Street's STOK Position: Q1 2026 in Review

Jane Street reduced its Stoke Therapeutics (STOK) stake by 4.1% in Q1 2026, selling an estimated $90.6K and leaving 64,349 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #4990.

Jane Street first reported a position in STOK in Q2 2020 and has held it in 16 quarters since. The position peaked at $4.06M in Q3 2024. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Jane Street held 64,349 shares of Stoke Therapeutics worth $2.1M as of Q1 2026.
  • Jane Street sold 2,763 Stoke Therapeutics shares in Q1 2026, an estimated $90.6K.
  • Stoke Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4990 holding.
  • Jane Street first reported a position in Stoke Therapeutics in Q2 2020 and has held it in 16 quarters since.
  • Jane Street's Stoke Therapeutics position peaked at $4.06M in Q3 2024.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.